Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 225-863-2 | CAS number: 5124-30-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Nov - Feb 2003
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 004
- Report date:
- 2004
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- Version / remarks:
- (1997)
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- in vitro mammalian chromosome aberration test
Test material
- Reference substance name:
- 4,4'-methylenedicyclohexyl diisocyanate
- EC Number:
- 225-863-2
- EC Name:
- 4,4'-methylenedicyclohexyl diisocyanate
- Cas Number:
- 5124-30-1
- Molecular formula:
- C15H22N2O2
- IUPAC Name:
- 1,1'-methylenebis(4-isocyanatocyclohexane)
- Details on test material:
- - Content: not indicated by the sponsor
- Stability under test conditions: A stability test in the solvent did not reveal significant degradation of the active ingredient.
Constituent 1
- Specific details on test material used for the study:
- - Stability under test conditions: A stability test in the solvent did not reveal significant degradation of the active ingredient.
Method
- Target gene:
- not applicable
Species / strain
- Species / strain / cell type:
- Chinese hamster lung fibroblasts (V79)
- Details on mammalian cell type (if applicable):
- - Type and identity of media: Eagle's minimal essential medium (MEM, Earle) with supplements
- Periodically checked for Mycoplasma contamination: yes
- Periodically checked for karyotype stability: yes
- Cytokinesis block (if used):
- 0.2 mL Colcemid solution (40 µg/mL water)
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9-mix from liver homogenates of Aroclor 1254 induced male Spargue Dawley rats.
- Test concentrations with justification for top dose:
- Experiment I (4-hours treatment, harvest time 18 hours): without S9 mix 0, 1.5, 3, 4.5, 6 and 7.5 µg/mL, with S9 mix 0, 6, 12, 20, 24 and 28 µg/mL
Experiment II (4-hours treatment, harvest time 30 hours): without S9 mix 0, 4.5, 6 and 7.5 µg/mL, with S9 mix 0, 20, 24 and 28 µg/mL
Experiment III (continuous treatment for 18 hours): without S9 mix 0, 2.5, 5, 8, 10 and 12 µg/mL - Vehicle / solvent:
- DMSO
Controls
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- mitomycin C
- Remarks:
- CP (2 µg/mL) was only used with S9-mix, MMC (4-hour treatment 0.1 µg/mL, 18-hour treatment 0.03 µg/mL) was only used without S9-mix
- Details on test system and experimental conditions:
- PRETESTING: Cells were exposed (in duplicate) for a 4 hour-treatment time to concentrations of 1-8 µg/mL without S9-mix and to concentrations of 10-50 µg/mL with S9-mix. Pre-test concentrations for the 18 hour-continuous treatment were 1-25 µg/mL. As indicators of cytotoxic effects mitotic indices and numbers of surviving cells (survival index) were used.
TREATMENT RPOTOCOL FOR MAIN TESTING: The general protocol was similar to published procedures (e.g. Dean and Danford, in: Mutagenicity testing - a practical approach, (ed. Venitt and Parry) IRL Press, Oxford, 1984).
Initially Chinese hamster V79 cells were exposed in the absence of S9 mix for 4 hours to concentrations of 0, 1.5, 3, 4.5, 6 and 7.5 µg/mL of test substance. Cultures of all concentrations were harvested 18 hours after the beginning of the treatment. In addition, cells treated with 0, 4.5, 6 and 7.5 µg/ml were harvested 30 hours after the beginning of the treatment. In the presence of S9 mix cells were exposed to concentrations of 0, 6, 12, 20, 24 and 28 µg/ml of test substance. Cultures of all concentrations were harvested 18 hours after the beginning of the treatment. In addition, cells treated with 0, 20, 24 and 28 µg/ml were harvested 30 hours after the beginning of the treatment. Without S9 mix an additional experiment was performed using continuous treatment for 18 hours, harvest at the same time, and test substance-concentrations of 0, 2.5, 5, 8, 10 and 12 µg/ml.
Based on their cytotoxicity, which was also determined 8 hours after the beginning of the treatment, concentrations were selected for reading of metaphases.
NUMBER OF CELLS EVALUATED: Chromosomes of approximately 200 metaphases per concentration, 100 metaphases from each of two parallel cultures, were examined. The classes of structural chromosome damage were defined and recorded by using essentially the terminology of Rieger and Michaelis (Die Chromosomenmutationen, VEB Gustav-Fischer Verlag, Jena, 1967). Both chromatid and chromosome-type aberrations were assessed.
Polyploid metaphases were recorded.
SPINDLE INHIBITOR (cytogenetic assays): 0.2 ml Colcemid-solution (40 µg/ml water) was added to each flask two hours prior to the end of the incubation period.
STAIN (for cytogenetic assays): 3% Giemsa solution
DETERMINATION OF CYTOTOXICITY: was assessed in the pre-test as well as in the main-study.
- Method: Cell survival as well as mitotic index were determined in the presence and absence of S9 mix.
OTHER: Influence on pH and osmolality was assessed. - Evaluation criteria:
- - An increased incident of gaps of both types without concomitant increase of other aberration types was not considered as indication of a clastogenic effect.
- A test was considered positive, if there was a relevant and statistically significant increase in the aberration rate.
- A test was considered negative, if there was no such increase at any time interval.
- A test was also considered negative, if there were statistical significant values, which were, however, within the range of historical negative controls.
- A test was considered equivocal, if there was an increase above the range of historical negative controls which was statistically significant but not considered relevant, or if an increase occurred, which was considered relevant, but which was not statistically significant. - Statistics:
- Pair-wise comparison of treated and positive control groups to the respective solvent control group.
The statistical analysis used the one-sided chi²-test for the mitotic index, the recommendations outlined by Richardson et. al. (1989) and the Fisher's exact test for assessing the numbers of metaphases with aberrations/exchanges.
A difference was considered to be significant, if the probability of error was below 5%.
Results and discussion
Test results
- Species / strain:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- Concentrations of 4.5, 6 and 7.5 µg/mL test substance (4 hours treatment) and 2.5, 5 and 8 µg/ml (18 hours treatment) were chosen for reading in the absence of S9-mix. In the presence of S9-mix 6, 12 and 20 µg/mL test substance concentrations were employed. All of these cultures harvested 18 hours after the beginning of the treatment were included. In addition, cultures treated in the absence of S9-mix with 7.5 µg/mL and harvested 30 hours after the beginning of the treatment were used. The same was true for cultures treated in the presence of S9-mix with 20 µg/mL.
None of the cultures treated with test substance in the absence and in the presence of S9-mix showed biologically relevant or statistically significant increased numbers of aberrant metaphases.
TEST-SPECIFIC CONFOUNDING FACTORS
- Effects of pH: Concentrations of up to at least 500 µg/mL did not change the pH in the medium in the pre-test.
- Effects of osmolality: The osmolality in the medium of the pre-test was not changed by concentrations of up to at least 500 µg/mL.
- Precipitation: Precipitation in the medium was not observed.
ADDITIONAL INFORMATION ON CYTOTOXICITY: Without S9-mix cytotoxic effects were observed at 4.5 µg/mL and above after 4 hours treatment and at 8 µg/mL and above after 18 hours treatment. With S9-mix cytotoxic effects were observed at 12 µg/mL and above.
Any other information on results incl. tables
Data from IUCLID4
RS-Freetext:
Without S9 mix cytotoxic effects were observed at 4.5 µg/ml and above after 4 hours treatment and at 8 µg/ml and above after 18 hours treatment. With S9 mix cytotoxic effects
were observed at 12 µg/ml and above. Precipitation in the medium was not observed.
Therefore, concentrations of 4.5, 6 and 7.5 µg/ml test substance (4 hours treatment) and 2.5, 5 and 8 µg/ml (18 hours treatment) were chosen for reading in the absence of S9
mix. In the presence of S9 mix 6, 12 and 20 µg/ml of test substance were employed. All of these cultures harvested 18 hours after the beginning of the treatment were included. In addition, cultures treated in the absence of S9 mix with 7.5 µg/ml and harvested 30 hours after the beginning of the treatment were used. The same was true for cultures treated in the presence of S9 mix with 20 µg/ml.
None of the cultures treated with test substance in the absence and in the presence of S9 mix showed biologically relevant or statistically significant increased numbers of aberrant metaphases.
Applicant's summary and conclusion
- Executive summary:
4,4´-Methylenedicyclohexyl diisocyanate has been assessed in the OECD HPV programme, 2005.
Cited from SIAR of SIAM 20 (Paris, April 19 -22, 2005): "4,4´-Methylenedicyclohexyl diisocyanate was tested in the chromosome aberration assay with Chinese hamster V79 cells in vitro according to OECD TG 473. None of the cultures treated with 4,4´-methylenedicyclohexyl diisocyanate in the absence and in the presence of S9 mix up to cytotoxic concentrations (4.5 μg/ml without S9 mix and 12 mg/ml with S9 mix) showed biologically relevant or statistically significant increased numbers of aberrant metaphases. The positive controls induced clastogenic effects."
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.